Literature DB >> 10453254

Emerging infectious diseases and risk to the traveler.

D O Freedman1, J Woodall.   

Abstract

This article examines the relationship between travel and emerging infections. The authors begin with an overview of disease emergence and follow with a brief infection-by-infection examination of selected emerging pathogens of particular relevance to travelers and the medical care providers who counsel them. Emphasis is given to those agents that clearly have emerged as significant new or increased risk to travelers; or are of sufficiently new interest, even in the face of inadequate data in travelers, to be of potential immediate concern. The authors also discuss several novel pathogens, such as Ebola virus, that are clearly of insignificant or minimal risk to travelers, but are the subject of frequent questions from patients requesting pre-travel advice from medical providers.

Entities:  

Mesh:

Year:  1999        PMID: 10453254

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  18 in total

1.  Characterization of the interaction of lassa fever virus with its cellular receptor alpha-dystroglycan.

Authors:  Stefan Kunz; Jillian M Rojek; Mar Perez; Christina F Spiropoulou; Michael B A Oldstone
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

2.  Residues K465 and G467 within the Cytoplasmic Domain of GP2 Play a Critical Role in the Persistence of Lymphocytic Choriomeningitis Virus in Mice.

Authors:  Masaharu Iwasaki; Cherie T Ng; Beatrice Cubitt; Juan C de la Torre
Journal:  J Virol       Date:  2016-10-28       Impact factor: 5.103

3.  The ReFRAME library as a comprehensive drug repurposing library to identify mammarenavirus inhibitors.

Authors:  Yu-Jin Kim; Beatrice Cubitt; Emily Chen; Mitchell V Hull; Arnab K Chatterjee; Yingyun Cai; Jens H Kuhn; Juan C de la Torre
Journal:  Antiviral Res       Date:  2019-07-11       Impact factor: 5.970

4.  The High Degree of Sequence Plasticity of the Arenavirus Noncoding Intergenic Region (IGR) Enables the Use of a Nonviral Universal Synthetic IGR To Attenuate Arenaviruses.

Authors:  Masaharu Iwasaki; Beatrice Cubitt; Brian M Sullivan; Juan C de la Torre
Journal:  J Virol       Date:  2016-01-06       Impact factor: 5.103

5.  Pathogenesis of Lassa fever virus infection: I. Susceptibility of mice to recombinant Lassa Gp/LCMV chimeric virus.

Authors:  Andrew M Lee; Justin Cruite; Megan J Welch; Brian Sullivan; Michael B A Oldstone
Journal:  Virology       Date:  2013-05-16       Impact factor: 3.616

6.  General Molecular Strategy for Development of Arenavirus Live-Attenuated Vaccines.

Authors:  Masaharu Iwasaki; Nhi Ngo; Beatrice Cubitt; John R Teijaro; Juan C de la Torre
Journal:  J Virol       Date:  2015-09-23       Impact factor: 5.103

7.  Different mechanisms of cell entry by human-pathogenic Old World and New World arenaviruses.

Authors:  Jillian M Rojek; Ana B Sanchez; Ngoc Thao Nguyen; Juan-Carlos de la Torre; Stefan Kunz
Journal:  J Virol       Date:  2008-05-28       Impact factor: 5.103

Review 8.  Novel strategies for development of hemorrhagic fever arenavirus live-attenuated vaccines.

Authors:  Luis Martinez-Sobrido; Juan Carlos de la Torre
Journal:  Expert Rev Vaccines       Date:  2016-05-13       Impact factor: 5.217

9.  Reverse Genetics Approaches to Control Arenavirus.

Authors:  Luis Martínez-Sobrido; Benson Yee Hin Cheng; Juan Carlos de la Torre
Journal:  Methods Mol Biol       Date:  2016

Review 10.  Reverse genetics approaches to combat pathogenic arenaviruses.

Authors:  Juan C de la Torre
Journal:  Antiviral Res       Date:  2008-09-07       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.